Cargando…
Aminoglycosides and their potential as SARS-CoV-2 antivirals
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985687/ https://www.ncbi.nlm.nih.gov/pubmed/33780777 http://dx.doi.org/10.1016/j.mehy.2021.110559 |
| _version_ | 1783668299612028928 |
|---|---|
| author | Cimolai, Nevio |
| author_facet | Cimolai, Nevio |
| author_sort | Cimolai, Nevio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7985687 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79856872021-03-23 Aminoglycosides and their potential as SARS-CoV-2 antivirals Cimolai, Nevio Med Hypotheses Letter to Editors Elsevier Ltd. 2021-05 2021-03-23 /pmc/articles/PMC7985687/ /pubmed/33780777 http://dx.doi.org/10.1016/j.mehy.2021.110559 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editors Cimolai, Nevio Aminoglycosides and their potential as SARS-CoV-2 antivirals |
| title | Aminoglycosides and their potential as SARS-CoV-2 antivirals |
| title_full | Aminoglycosides and their potential as SARS-CoV-2 antivirals |
| title_fullStr | Aminoglycosides and their potential as SARS-CoV-2 antivirals |
| title_full_unstemmed | Aminoglycosides and their potential as SARS-CoV-2 antivirals |
| title_short | Aminoglycosides and their potential as SARS-CoV-2 antivirals |
| title_sort | aminoglycosides and their potential as sars-cov-2 antivirals |
| topic | Letter to Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985687/ https://www.ncbi.nlm.nih.gov/pubmed/33780777 http://dx.doi.org/10.1016/j.mehy.2021.110559 |
| work_keys_str_mv | AT cimolainevio aminoglycosidesandtheirpotentialassarscov2antivirals |